Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
DQB1-FL8 is a humanized monoclonal antibody that acts as a biosimilar targeting the HLA class II histocompatibility antigen specifically the DQ beta 1 chain. This antigen is part of the major histocompatibility complex (MHC) which plays a crucial role in the immune system's recognition of foreign substances. The biosimilar's function is to modulate immune responses by interacting with HLA-DQB making it potentially useful in research studies related to autoimmune diseases or organ transplantation where immune regulation is pivotal. The DQB1-FL8 is typically provided in research settings in formulations designed to ensure stability and effectiveness in experimental therapies. Its application within laboratory settings aids in the exploration of immunological pathways and therapeutic interventions related to dysfunctional immune responses.
仅用于科研。不用于诊断过程。未经明确授权不得转售。